Ronit Harpaz

Part of Vishay Intertechnology, Inc., Vishay Israel Ltd. is an Israeli company that manufactures discrete semiconductors and passive electronic components. The company is based in Petach Tikva, Israel.

POCARED Diagnostics Ltd. engages in developing diseases diagnostic technologies, with the purpose of optimizing antibiotic stewardship, patient care and laboratory efficiency. Its pipeline includes rapid antimicrobial susceptibility technology. The company was founded by Jonathan Gurfinkel, and Gal Ingber in 2004 and is headquartered in Rehovot, Israel.

Vitalife Life Sciences Fund LP seeks investment opportunities in companies located in Israel. The fund targets companies operating in the fields of medical devices, drug discovery, drug delivery and bio-informatics. It provides financing for early stage capital requirement with an investment size ranging from$0.5 to $5 million. It acts as a lead investor.

NewPace Ltd. develops a novel implantable subcutaneous string defibrillator. It is used for the prevention of cardiac arrest. The company was founded by Robert S. Fishel in 2012 and is headquartered in Caesarea, Israel.

Illumigyn Ltd. is a bio technology company. Its product Gynescope is an advanced (patented) imaging colposcope that delivers down to 15 micron image resolution over a wide field of view and a range of working distances, coupled with multispectral illumination options, in order to reduce the inherent subjectivity of colposcopy and cervical exams thus enabling early detection of cervical cancer while meaningfully reducing misdiagnosis. The company was founded by Lior Greenstein in 2012 and is headquartered in Neve Ilan, Israel.

SCP Vitalife Management Co. LLC provides investment advice. The private company is based in Wayne, PA. The company was founded by Wayne B. Weisman.

ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA.

Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel.

Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

Filterlex Medical Ltd. develops embolic protection devices to reduce the risk of stroke and other complications during catheter-based structural heart procedures. It offers CAPTIS is a next-generation full-body embolic protection device. The company was founded by Sigal Eli, Eyal Teichman, Giora Weisz and Ron Davidson in 2015 and is headquartered in Yoknea, Israel.

MST Medical Surgery Technologies Ltd. develops image guided solutions for laparoscopy. Its product AutoLap, an image-based laparoscope positioning system for minimally invasive surgical procedures. The firm offers the surgeon full and natural control of the laparoscope and exceptional intraoperative image capabilities and the freedom to fully focus on the surgical procedure. The company was founded by Ziv Tamir and Moti Sholev in 2005 and is headquartered in Yokneam, Israel.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities.

Trig Medical Ltd. engages in the development of medical monitoring systems. Its products are LaborPro, and TrigGuide. Trig Medical was founded by Yoav Paltieli on February 20, 2001 and is headquartered in Nesher, Israel.

Mediguide Ltd. develops tracking and imaging technology for surgical procedures. The company develops technology an applications for intra-body navigation. It navigates minimal invasive surgery tools such as catheters, endoscopes, and needles. Mediguide was founded in 2001 and is headquartered in Haifa, Israel

SCP Vitalife Partners (SCP Vitalife) is a venture capital firm founded in 2000 by Dr. Abraham Ludomirski and Wayne B. Weisman. The firm is headquartered in Malvern, Philadelphia with additional office in Israel.

Stryker GI Ltd. develops, manufactures and markets advanced endoscopic solutions for gastroenterological applications. The company was formerly known as SightLine Technologies. Stryker GI Israel was founded by Giora Bernat in December 1994 and is located in Haifa, Israel.

Medison Pharma Ltd. markets and distributes medical, pharmaceutical, and diagnostics devices and products. It offers services like registration, reimbursement, nursing, distribution, and marketing. The firm is a marketing group, which represents niche healthcare products from companies such as Biogen Idec, Amgen, Shire and Ipsen. The company was founded by Meir Jakobsohn in 1996 and is headquartered in Petach Tikva, Israel.

Sensible Medical Innovations Ltd. develops non-invasive devices for monitoring congestive heart failures. The firm also developed an imaging method for internal organs based on information technology. The company was founded by Nadav Mizrahi, Amir Soroka, Dan Rappaport, Amir Ronen and Shlomi Bergida in 2007 and is headquartered in Netanya, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel.